Alexander J.H. Fedorec

Nov 1, 2024 | biorxiv.org | Sara Hestehave |Roxana Florea |Samuel Singleton |Alexander J.H. Fedorec

AbstractChronic secondary musculoskeletal pain affects 20-30% of the population and includes sensory disturbances and emotional comorbidities, such as anxiety and depression, which reduce quality of life. We monitored a pre-clinical model of persistent joint pain for 6 months and found that sensory and functional changes were immediate while anxio-depressive comorbidities appeared from 3 months onwards.